Table 2 Percentage of GPs with positive, neutral and negative behaviours for each specific indicator (row frequencies)

From: Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting

 

Baseline

At 12 months

At 24 months

Indicator

Negative

Neutral

Positive

Negative

Neutral

Positive

Negative

Neutral

Positive

2. Spirometry lifetime

14 (42.4)

6 (18.2)

13 (39.4)

10 (30.3)

14 (42.4)

9 (27.3)

11 (33.3)

13 (39.4)

9 (27.3)

3. Spirometry lifetime among smokers

12 (36.4)

10 (30.3)

11 (33.3)

10 (30.3)

13 (39.4)

10 (30.3)

9 (27.3)

14 (42.4)

10 (30.3)

4. Spirometry in the last year

11 (33.3)

15 (45.5)

7 (21.2)

14 (42.4)

7 (21.2)

12 (36.4)

12 (36.4)

11 (33.3)

10 (30.3)

5. Mean n. spirometry in the last 2 years

11 (33.3)

15 (45.5)

7 (21.2)

14 (42.4)

12 (36.4)

7 (21.2)

10 (30.3)

17 (51.5)

6 (18.2)

6. BMI registration lifetime

11 (33.3)

9 (27.3)

13 (39.4)

11 (33.3)

8 (24.2)

14 (42.4)

11 (33.3)

10 (30.3)

12 (36.4)

7. Smoking registration lifetime

13 (39.4)

9 (27.3)

11 (33.3)

12 (36.4)

10 (30.3)

11 (33.3)

12 (36.4)

11 (33.3)

10 (30.3)

8. Influenza vaccination in the last year

5 (15.2)

19 (57.6)

9 (27.3)

11 (33.3)

9 (27.3)

13 (39.4)

9 (27.3)

13 (39.4)

11 (33.3)

9. Pneumococcal vaccination in the last 4 years

9 (27.3)

12 (36.4)

12 (36.4)

12 (36.4)

9 (27.3)

12 (36.4)

11 (33.3)

8 (24.2)

14 (42.4)

10. Drugs targeting obstructive airway diseases in the last year

8 (24.2)

12 (36.4)

13 (39.4)

9 (27.3)

15 (45.5)

9 (27.3)

10 (30.3)

13 (39.4)

10 (30.3)

11. ICS in monotherapy in the last year

9 (27.3)

15 (45.5)

9 (27.3)

9 (27.3)

14 (42.4)

10 (30.3)

9 (27.3)

14 (42.4)

10 (30.3)

12. Occasional use of LABA and/or LAMA (±ICS) in the last year

8 (24.2)

19 (57.6)

6 (18.2)

3 (9.1)

27 (81.8)

3 (9.1)

6 (18.2)

22 (66.7)

5 (15.2)

13. Leukotriene receptor antagonists use in the last year

9 (27.3)

13 (39.4)

11 (33.3)

9 (27.3)

13 (39.4)

11 (33.3)

9 (27.3)

13 (39.4)

11 (33.3)

14. Low adherence to LABA and/or LAMA (±ICS)

5 (15.2)

20 (60.6)

8 (24.2)

0 (0)

32 (97.0)

1 (3.0)

6 (18.2)

19 (57.6)

8 (24.2)

15. Prolonged use of ICS

5 (15.2)

27 (81.8)

1 (3.0)

0 (0)

33 (100)

0 (0)

0 (0)

33 (100)

0 (0)

  1. Legend: from indicator n.2 to n.10: ‘positive’, ‘neutral’ and ‘negative’ behaviours were referred to be above, within and below the mean of the estimated registrations proportion, respectively. From indicator n.11 to n.15: ‘positive’, ‘neutral’ and ‘negative’ behaviours were referred to be below, within and above the mean of the estimated registrations proportion, respectively
Back to article page